nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—AR—scrotum—muscle cancer	0.118	0.279	CbGeAlD
Levonorgestrel—SHBG—hindlimb—muscle cancer	0.0562	0.132	CbGeAlD
Levonorgestrel—SRD5A1—renal system—muscle cancer	0.0333	0.0783	CbGeAlD
Levonorgestrel—SRD5A1—head—muscle cancer	0.0223	0.0524	CbGeAlD
Levonorgestrel—SRD5A1—testis—muscle cancer	0.0215	0.0506	CbGeAlD
Levonorgestrel—PGR—smooth muscle tissue—muscle cancer	0.0113	0.0267	CbGeAlD
Levonorgestrel—ESR1—embryo—muscle cancer	0.0113	0.0266	CbGeAlD
Levonorgestrel—SHBG—bone marrow—muscle cancer	0.00916	0.0216	CbGeAlD
Levonorgestrel—AR—smooth muscle tissue—muscle cancer	0.00903	0.0213	CbGeAlD
Levonorgestrel—ESR1—smooth muscle tissue—muscle cancer	0.00886	0.0209	CbGeAlD
Levonorgestrel—SHBG—vagina—muscle cancer	0.00877	0.0207	CbGeAlD
Levonorgestrel—AR—renal system—muscle cancer	0.00869	0.0205	CbGeAlD
Levonorgestrel—ESR1—renal system—muscle cancer	0.00853	0.0201	CbGeAlD
Levonorgestrel—PGR—vagina—muscle cancer	0.0079	0.0186	CbGeAlD
Levonorgestrel—SHBG—testis—muscle cancer	0.00783	0.0184	CbGeAlD
Levonorgestrel—AR—cardiac atrium—muscle cancer	0.00778	0.0183	CbGeAlD
Levonorgestrel—PGR—head—muscle cancer	0.0073	0.0172	CbGeAlD
Levonorgestrel—PGR—testis—muscle cancer	0.00705	0.0166	CbGeAlD
Levonorgestrel—AR—tendon—muscle cancer	0.00679	0.016	CbGeAlD
Levonorgestrel—CYP19A1—head—muscle cancer	0.00657	0.0155	CbGeAlD
Levonorgestrel—CYP19A1—testis—muscle cancer	0.00635	0.0149	CbGeAlD
Levonorgestrel—AR—vagina—muscle cancer	0.0063	0.0148	CbGeAlD
Levonorgestrel—ESR1—vagina—muscle cancer	0.00618	0.0146	CbGeAlD
Levonorgestrel—AR—head—muscle cancer	0.00582	0.0137	CbGeAlD
Levonorgestrel—ESR1—head—muscle cancer	0.00571	0.0134	CbGeAlD
Levonorgestrel—AR—testis—muscle cancer	0.00562	0.0132	CbGeAlD
Levonorgestrel—ESR1—testis—muscle cancer	0.00552	0.013	CbGeAlD
Levonorgestrel—CYP3A4—renal system—muscle cancer	0.00476	0.0112	CbGeAlD
Levonorgestrel—Discomfort—Dactinomycin—muscle cancer	0.00235	0.00408	CcSEcCtD
Levonorgestrel—Cystitis noninfective—Doxorubicin—muscle cancer	0.00234	0.00407	CcSEcCtD
Levonorgestrel—Influenza like illness—Doxorubicin—muscle cancer	0.00233	0.00404	CcSEcCtD
Levonorgestrel—Cystitis—Doxorubicin—muscle cancer	0.00231	0.00402	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Etoposide—muscle cancer	0.00231	0.00401	CcSEcCtD
Levonorgestrel—Anaemia—Vincristine—muscle cancer	0.0023	0.004	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Etoposide—muscle cancer	0.00229	0.00398	CcSEcCtD
Levonorgestrel—Candida infection—Doxorubicin—muscle cancer	0.00229	0.00397	CcSEcCtD
Levonorgestrel—Oedema—Dactinomycin—muscle cancer	0.00228	0.00396	CcSEcCtD
Levonorgestrel—Fluid retention—Doxorubicin—muscle cancer	0.00227	0.00395	CcSEcCtD
Levonorgestrel—Urethral disorder—Etoposide—muscle cancer	0.00227	0.00395	CcSEcCtD
Levonorgestrel—Infection—Dactinomycin—muscle cancer	0.00226	0.00393	CcSEcCtD
Levonorgestrel—Vaginal infection—Doxorubicin—muscle cancer	0.00226	0.00393	CcSEcCtD
Levonorgestrel—Vertigo—Vincristine—muscle cancer	0.00224	0.00389	CcSEcCtD
Levonorgestrel—Cramps of lower extremities—Doxorubicin—muscle cancer	0.0022	0.00382	CcSEcCtD
Levonorgestrel—Erythema multiforme—Etoposide—muscle cancer	0.00219	0.00381	CcSEcCtD
Levonorgestrel—Anorexia—Dactinomycin—muscle cancer	0.00217	0.00377	CcSEcCtD
Levonorgestrel—Eye disorder—Etoposide—muscle cancer	0.00217	0.00377	CcSEcCtD
Levonorgestrel—Bladder pain—Doxorubicin—muscle cancer	0.00217	0.00376	CcSEcCtD
Levonorgestrel—Neoplasm—Doxorubicin—muscle cancer	0.00217	0.00376	CcSEcCtD
Levonorgestrel—Cardiac disorder—Etoposide—muscle cancer	0.00215	0.00374	CcSEcCtD
Levonorgestrel—Hypertension—Vincristine—muscle cancer	0.00215	0.00374	CcSEcCtD
Levonorgestrel—Myalgia—Vincristine—muscle cancer	0.00212	0.00369	CcSEcCtD
Levonorgestrel—Immune system disorder—Etoposide—muscle cancer	0.00209	0.00364	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Etoposide—muscle cancer	0.00209	0.00363	CcSEcCtD
Levonorgestrel—Abnormal vision—Doxorubicin—muscle cancer	0.00209	0.00363	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00207	0.0036	CcSEcCtD
Levonorgestrel—Alopecia—Etoposide—muscle cancer	0.00205	0.00356	CcSEcCtD
Levonorgestrel—Oedema—Vincristine—muscle cancer	0.00203	0.00353	CcSEcCtD
Levonorgestrel—Infection—Vincristine—muscle cancer	0.00202	0.00351	CcSEcCtD
Levonorgestrel—Nervous system disorder—Vincristine—muscle cancer	0.00199	0.00347	CcSEcCtD
Levonorgestrel—Decreased appetite—Dactinomycin—muscle cancer	0.00198	0.00344	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Vincristine—muscle cancer	0.00197	0.00342	CcSEcCtD
Levonorgestrel—Fatigue—Dactinomycin—muscle cancer	0.00196	0.00341	CcSEcCtD
Levonorgestrel—Back pain—Etoposide—muscle cancer	0.00195	0.00339	CcSEcCtD
Levonorgestrel—Pain—Dactinomycin—muscle cancer	0.00195	0.00338	CcSEcCtD
Levonorgestrel—Vascular purpura—Doxorubicin—muscle cancer	0.00194	0.00338	CcSEcCtD
Levonorgestrel—Muscle spasms—Etoposide—muscle cancer	0.00194	0.00337	CcSEcCtD
Levonorgestrel—Anorexia—Vincristine—muscle cancer	0.00194	0.00337	CcSEcCtD
Levonorgestrel—Eczema—Doxorubicin—muscle cancer	0.00193	0.00336	CcSEcCtD
Levonorgestrel—Mood swings—Methotrexate—muscle cancer	0.0019	0.00331	CcSEcCtD
Levonorgestrel—Anaemia—Etoposide—muscle cancer	0.00187	0.00324	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00186	0.00323	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00185	0.00322	CcSEcCtD
Levonorgestrel—Increased appetite—Doxorubicin—muscle cancer	0.00185	0.00322	CcSEcCtD
Levonorgestrel—Insomnia—Vincristine—muscle cancer	0.00184	0.0032	CcSEcCtD
Levonorgestrel—Breast disorder—Methotrexate—muscle cancer	0.00181	0.00315	CcSEcCtD
Levonorgestrel—Vertigo—Etoposide—muscle cancer	0.00181	0.00315	CcSEcCtD
Levonorgestrel—Purpura—Doxorubicin—muscle cancer	0.0018	0.00313	CcSEcCtD
Levonorgestrel—Abdominal pain—Dactinomycin—muscle cancer	0.0018	0.00313	CcSEcCtD
Levonorgestrel—Body temperature increased—Dactinomycin—muscle cancer	0.0018	0.00313	CcSEcCtD
Levonorgestrel—Loss of consciousness—Etoposide—muscle cancer	0.00177	0.00308	CcSEcCtD
Levonorgestrel—Decreased appetite—Vincristine—muscle cancer	0.00177	0.00307	CcSEcCtD
Levonorgestrel—Cough—Etoposide—muscle cancer	0.00176	0.00306	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Vincristine—muscle cancer	0.00176	0.00305	CcSEcCtD
Levonorgestrel—Fatigue—Vincristine—muscle cancer	0.00175	0.00305	CcSEcCtD
Levonorgestrel—Hypertension—Etoposide—muscle cancer	0.00174	0.00303	CcSEcCtD
Levonorgestrel—Pain—Vincristine—muscle cancer	0.00174	0.00302	CcSEcCtD
Levonorgestrel—Constipation—Vincristine—muscle cancer	0.00174	0.00302	CcSEcCtD
Levonorgestrel—Pain in extremity—Doxorubicin—muscle cancer	0.00174	0.00302	CcSEcCtD
Levonorgestrel—Asthma—Methotrexate—muscle cancer	0.00174	0.00302	CcSEcCtD
Levonorgestrel—Chest pain—Etoposide—muscle cancer	0.00172	0.00299	CcSEcCtD
Levonorgestrel—Affect lability—Doxorubicin—muscle cancer	0.00171	0.00297	CcSEcCtD
Levonorgestrel—Migraine—Doxorubicin—muscle cancer	0.00171	0.00297	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00171	0.00297	CcSEcCtD
Levonorgestrel—Discomfort—Etoposide—muscle cancer	0.0017	0.00295	CcSEcCtD
Levonorgestrel—Hypersensitivity—Dactinomycin—muscle cancer	0.00168	0.00291	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Vincristine—muscle cancer	0.00166	0.00289	CcSEcCtD
Levonorgestrel—Mood swings—Doxorubicin—muscle cancer	0.00165	0.00286	CcSEcCtD
Levonorgestrel—Infection—Etoposide—muscle cancer	0.00164	0.00284	CcSEcCtD
Levonorgestrel—Asthenia—Dactinomycin—muscle cancer	0.00163	0.00284	CcSEcCtD
Levonorgestrel—Dysuria—Methotrexate—muscle cancer	0.00162	0.00282	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00161	0.0028	CcSEcCtD
Levonorgestrel—Body temperature increased—Vincristine—muscle cancer	0.00161	0.00279	CcSEcCtD
Levonorgestrel—Abdominal pain—Vincristine—muscle cancer	0.00161	0.00279	CcSEcCtD
Levonorgestrel—Skin disorder—Etoposide—muscle cancer	0.0016	0.00278	CcSEcCtD
Levonorgestrel—Dry skin—Doxorubicin—muscle cancer	0.00159	0.00277	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Etoposide—muscle cancer	0.00159	0.00277	CcSEcCtD
Levonorgestrel—Breast disorder—Doxorubicin—muscle cancer	0.00157	0.00273	CcSEcCtD
Levonorgestrel—Anorexia—Etoposide—muscle cancer	0.00157	0.00273	CcSEcCtD
Levonorgestrel—Diarrhoea—Dactinomycin—muscle cancer	0.00156	0.00271	CcSEcCtD
Levonorgestrel—Pneumonia—Methotrexate—muscle cancer	0.00156	0.0027	CcSEcCtD
Levonorgestrel—Infestation—Methotrexate—muscle cancer	0.00155	0.00269	CcSEcCtD
Levonorgestrel—Infestation NOS—Methotrexate—muscle cancer	0.00155	0.00269	CcSEcCtD
Levonorgestrel—Depression—Methotrexate—muscle cancer	0.00154	0.00268	CcSEcCtD
Levonorgestrel—Abdominal distension—Doxorubicin—muscle cancer	0.00151	0.00263	CcSEcCtD
Levonorgestrel—Influenza—Doxorubicin—muscle cancer	0.0015	0.00261	CcSEcCtD
Levonorgestrel—Asthma—Doxorubicin—muscle cancer	0.0015	0.00261	CcSEcCtD
Levonorgestrel—Hypersensitivity—Vincristine—muscle cancer	0.0015	0.0026	CcSEcCtD
Levonorgestrel—Dyspnoea—Etoposide—muscle cancer	0.00147	0.00255	CcSEcCtD
Levonorgestrel—Somnolence—Etoposide—muscle cancer	0.00146	0.00255	CcSEcCtD
Levonorgestrel—Asthenia—Vincristine—muscle cancer	0.00146	0.00254	CcSEcCtD
Levonorgestrel—Vomiting—Dactinomycin—muscle cancer	0.00145	0.00252	CcSEcCtD
Levonorgestrel—Bronchitis—Doxorubicin—muscle cancer	0.00145	0.00251	CcSEcCtD
Levonorgestrel—Rash—Dactinomycin—muscle cancer	0.00144	0.00249	CcSEcCtD
Levonorgestrel—Decreased appetite—Etoposide—muscle cancer	0.00143	0.00249	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Etoposide—muscle cancer	0.00142	0.00247	CcSEcCtD
Levonorgestrel—Fatigue—Etoposide—muscle cancer	0.00142	0.00247	CcSEcCtD
Levonorgestrel—Pain—Etoposide—muscle cancer	0.00141	0.00245	CcSEcCtD
Levonorgestrel—Constipation—Etoposide—muscle cancer	0.00141	0.00245	CcSEcCtD
Levonorgestrel—Dysuria—Doxorubicin—muscle cancer	0.00141	0.00244	CcSEcCtD
Levonorgestrel—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.0014	0.00243	CcSEcCtD
Levonorgestrel—Haemoglobin—Methotrexate—muscle cancer	0.0014	0.00243	CcSEcCtD
Levonorgestrel—Diarrhoea—Vincristine—muscle cancer	0.00139	0.00242	CcSEcCtD
Levonorgestrel—Haemorrhage—Methotrexate—muscle cancer	0.00139	0.00241	CcSEcCtD
Levonorgestrel—Pollakiuria—Doxorubicin—muscle cancer	0.00139	0.00241	CcSEcCtD
Levonorgestrel—Pharyngitis—Methotrexate—muscle cancer	0.00138	0.0024	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Methotrexate—muscle cancer	0.00137	0.00238	CcSEcCtD
Levonorgestrel—Weight increased—Doxorubicin—muscle cancer	0.00137	0.00238	CcSEcCtD
Levonorgestrel—Urethral disorder—Methotrexate—muscle cancer	0.00136	0.00237	CcSEcCtD
Levonorgestrel—Weight decreased—Doxorubicin—muscle cancer	0.00136	0.00236	CcSEcCtD
Levonorgestrel—Nausea—Dactinomycin—muscle cancer	0.00135	0.00235	CcSEcCtD
Levonorgestrel—Pneumonia—Doxorubicin—muscle cancer	0.00135	0.00234	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Etoposide—muscle cancer	0.00135	0.00234	CcSEcCtD
Levonorgestrel—Dizziness—Vincristine—muscle cancer	0.00134	0.00234	CcSEcCtD
Levonorgestrel—Infestation NOS—Doxorubicin—muscle cancer	0.00134	0.00233	CcSEcCtD
Levonorgestrel—Infestation—Doxorubicin—muscle cancer	0.00134	0.00233	CcSEcCtD
Levonorgestrel—Visual impairment—Methotrexate—muscle cancer	0.00134	0.00233	CcSEcCtD
Levonorgestrel—Erythema multiforme—Methotrexate—muscle cancer	0.00131	0.00228	CcSEcCtD
Levonorgestrel—Urticaria—Etoposide—muscle cancer	0.00131	0.00227	CcSEcCtD
Levonorgestrel—Abdominal pain—Etoposide—muscle cancer	0.0013	0.00226	CcSEcCtD
Levonorgestrel—Body temperature increased—Etoposide—muscle cancer	0.0013	0.00226	CcSEcCtD
Levonorgestrel—Urinary tract infection—Doxorubicin—muscle cancer	0.0013	0.00226	CcSEcCtD
Levonorgestrel—Eye disorder—Methotrexate—muscle cancer	0.0013	0.00226	CcSEcCtD
Levonorgestrel—Vomiting—Vincristine—muscle cancer	0.00129	0.00225	CcSEcCtD
Levonorgestrel—Cardiac disorder—Methotrexate—muscle cancer	0.00129	0.00224	CcSEcCtD
Levonorgestrel—Rash—Vincristine—muscle cancer	0.00128	0.00223	CcSEcCtD
Levonorgestrel—Dermatitis—Vincristine—muscle cancer	0.00128	0.00223	CcSEcCtD
Levonorgestrel—Headache—Vincristine—muscle cancer	0.00127	0.00221	CcSEcCtD
Levonorgestrel—Sinusitis—Doxorubicin—muscle cancer	0.00126	0.00218	CcSEcCtD
Levonorgestrel—Immune system disorder—Methotrexate—muscle cancer	0.00125	0.00218	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Methotrexate—muscle cancer	0.00125	0.00218	CcSEcCtD
Levonorgestrel—Alopecia—Methotrexate—muscle cancer	0.00123	0.00213	CcSEcCtD
Levonorgestrel—Mental disorder—Methotrexate—muscle cancer	0.00122	0.00211	CcSEcCtD
Levonorgestrel—Hypersensitivity—Etoposide—muscle cancer	0.00121	0.00211	CcSEcCtD
Levonorgestrel—Erythema—Methotrexate—muscle cancer	0.00121	0.0021	CcSEcCtD
Levonorgestrel—Malnutrition—Methotrexate—muscle cancer	0.00121	0.0021	CcSEcCtD
Levonorgestrel—Haemoglobin—Doxorubicin—muscle cancer	0.00121	0.0021	CcSEcCtD
Levonorgestrel—Nausea—Vincristine—muscle cancer	0.00121	0.0021	CcSEcCtD
Levonorgestrel—Rhinitis—Doxorubicin—muscle cancer	0.00121	0.0021	CcSEcCtD
Levonorgestrel—Haemorrhage—Doxorubicin—muscle cancer	0.0012	0.00209	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Doxorubicin—muscle cancer	0.0012	0.00208	CcSEcCtD
Levonorgestrel—Pharyngitis—Doxorubicin—muscle cancer	0.00119	0.00207	CcSEcCtD
Levonorgestrel—Urinary tract disorder—Doxorubicin—muscle cancer	0.00119	0.00206	CcSEcCtD
Levonorgestrel—Asthenia—Etoposide—muscle cancer	0.00118	0.00205	CcSEcCtD
Levonorgestrel—Connective tissue disorder—Doxorubicin—muscle cancer	0.00118	0.00205	CcSEcCtD
Levonorgestrel—Urethral disorder—Doxorubicin—muscle cancer	0.00118	0.00205	CcSEcCtD
Levonorgestrel—Back pain—Methotrexate—muscle cancer	0.00117	0.00203	CcSEcCtD
Levonorgestrel—Pruritus—Etoposide—muscle cancer	0.00117	0.00203	CcSEcCtD
Levonorgestrel—Visual impairment—Doxorubicin—muscle cancer	0.00116	0.00201	CcSEcCtD
Levonorgestrel—Erythema multiforme—Doxorubicin—muscle cancer	0.00114	0.00198	CcSEcCtD
Levonorgestrel—Diarrhoea—Etoposide—muscle cancer	0.00113	0.00196	CcSEcCtD
Levonorgestrel—Eye disorder—Doxorubicin—muscle cancer	0.00112	0.00195	CcSEcCtD
Levonorgestrel—Anaemia—Methotrexate—muscle cancer	0.00112	0.00194	CcSEcCtD
Levonorgestrel—Cardiac disorder—Doxorubicin—muscle cancer	0.00112	0.00194	CcSEcCtD
Levonorgestrel—Dizziness—Etoposide—muscle cancer	0.00109	0.00189	CcSEcCtD
Levonorgestrel—Immune system disorder—Doxorubicin—muscle cancer	0.00109	0.00189	CcSEcCtD
Levonorgestrel—Vertigo—Methotrexate—muscle cancer	0.00109	0.00189	CcSEcCtD
Levonorgestrel—Mediastinal disorder—Doxorubicin—muscle cancer	0.00108	0.00188	CcSEcCtD
Levonorgestrel—Arrhythmia—Doxorubicin—muscle cancer	0.00107	0.00187	CcSEcCtD
Levonorgestrel—Alopecia—Doxorubicin—muscle cancer	0.00106	0.00185	CcSEcCtD
Levonorgestrel—Cough—Methotrexate—muscle cancer	0.00106	0.00183	CcSEcCtD
Levonorgestrel—Mental disorder—Doxorubicin—muscle cancer	0.00105	0.00183	CcSEcCtD
Levonorgestrel—Vomiting—Etoposide—muscle cancer	0.00105	0.00182	CcSEcCtD
Levonorgestrel—Erythema—Doxorubicin—muscle cancer	0.00105	0.00182	CcSEcCtD
Levonorgestrel—Malnutrition—Doxorubicin—muscle cancer	0.00105	0.00182	CcSEcCtD
Levonorgestrel—Rash—Etoposide—muscle cancer	0.00104	0.00181	CcSEcCtD
Levonorgestrel—Dermatitis—Etoposide—muscle cancer	0.00104	0.0018	CcSEcCtD
Levonorgestrel—Headache—Etoposide—muscle cancer	0.00103	0.00179	CcSEcCtD
Levonorgestrel—Flatulence—Doxorubicin—muscle cancer	0.00103	0.00179	CcSEcCtD
Levonorgestrel—Chest pain—Methotrexate—muscle cancer	0.00103	0.00179	CcSEcCtD
Levonorgestrel—Myalgia—Methotrexate—muscle cancer	0.00103	0.00179	CcSEcCtD
Levonorgestrel—Tension—Doxorubicin—muscle cancer	0.00103	0.00179	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.00102	0.00178	CcSEcCtD
Levonorgestrel—Discomfort—Methotrexate—muscle cancer	0.00102	0.00177	CcSEcCtD
Levonorgestrel—Nervousness—Doxorubicin—muscle cancer	0.00102	0.00177	CcSEcCtD
Levonorgestrel—Back pain—Doxorubicin—muscle cancer	0.00101	0.00176	CcSEcCtD
Levonorgestrel—Muscle spasms—Doxorubicin—muscle cancer	0.00101	0.00175	CcSEcCtD
Levonorgestrel—Infection—Methotrexate—muscle cancer	0.00098	0.0017	CcSEcCtD
Levonorgestrel—Nausea—Etoposide—muscle cancer	0.000979	0.0017	CcSEcCtD
Levonorgestrel—Nervous system disorder—Methotrexate—muscle cancer	0.000968	0.00168	CcSEcCtD
Levonorgestrel—Anaemia—Doxorubicin—muscle cancer	0.000968	0.00168	CcSEcCtD
Levonorgestrel—Skin disorder—Methotrexate—muscle cancer	0.000959	0.00167	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Methotrexate—muscle cancer	0.000954	0.00166	CcSEcCtD
Levonorgestrel—Vertigo—Doxorubicin—muscle cancer	0.000941	0.00163	CcSEcCtD
Levonorgestrel—Anorexia—Methotrexate—muscle cancer	0.000941	0.00163	CcSEcCtD
Levonorgestrel—Syncope—Doxorubicin—muscle cancer	0.000939	0.00163	CcSEcCtD
Levonorgestrel—Palpitations—Doxorubicin—muscle cancer	0.000925	0.00161	CcSEcCtD
Levonorgestrel—Loss of consciousness—Doxorubicin—muscle cancer	0.00092	0.0016	CcSEcCtD
Levonorgestrel—Cough—Doxorubicin—muscle cancer	0.000914	0.00159	CcSEcCtD
Levonorgestrel—Hypertension—Doxorubicin—muscle cancer	0.000904	0.00157	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000899	0.00156	CcSEcCtD
Levonorgestrel—Insomnia—Methotrexate—muscle cancer	0.000893	0.00155	CcSEcCtD
Levonorgestrel—Myalgia—Doxorubicin—muscle cancer	0.000891	0.00155	CcSEcCtD
Levonorgestrel—Chest pain—Doxorubicin—muscle cancer	0.000891	0.00155	CcSEcCtD
Levonorgestrel—Anxiety—Doxorubicin—muscle cancer	0.000888	0.00154	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000885	0.00154	CcSEcCtD
Levonorgestrel—Discomfort—Doxorubicin—muscle cancer	0.000881	0.00153	CcSEcCtD
Levonorgestrel—Dyspnoea—Methotrexate—muscle cancer	0.00088	0.00153	CcSEcCtD
Levonorgestrel—Somnolence—Methotrexate—muscle cancer	0.000877	0.00152	CcSEcCtD
Levonorgestrel—Dyspepsia—Methotrexate—muscle cancer	0.000869	0.00151	CcSEcCtD
Levonorgestrel—Decreased appetite—Methotrexate—muscle cancer	0.000858	0.00149	CcSEcCtD
Levonorgestrel—Oedema—Doxorubicin—muscle cancer	0.000854	0.00149	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000852	0.00148	CcSEcCtD
Levonorgestrel—Fatigue—Methotrexate—muscle cancer	0.000851	0.00148	CcSEcCtD
Levonorgestrel—Infection—Doxorubicin—muscle cancer	0.000849	0.00148	CcSEcCtD
Levonorgestrel—Pain—Methotrexate—muscle cancer	0.000844	0.00147	CcSEcCtD
Levonorgestrel—Shock—Doxorubicin—muscle cancer	0.000841	0.00146	CcSEcCtD
Levonorgestrel—Nervous system disorder—Doxorubicin—muscle cancer	0.000838	0.00146	CcSEcCtD
Levonorgestrel—Skin disorder—Doxorubicin—muscle cancer	0.00083	0.00144	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Doxorubicin—muscle cancer	0.000826	0.00144	CcSEcCtD
Levonorgestrel—Anorexia—Doxorubicin—muscle cancer	0.000815	0.00142	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Methotrexate—muscle cancer	0.000807	0.0014	CcSEcCtD
Levonorgestrel—Urticaria—Methotrexate—muscle cancer	0.000784	0.00136	CcSEcCtD
Levonorgestrel—Abdominal pain—Methotrexate—muscle cancer	0.00078	0.00136	CcSEcCtD
Levonorgestrel—Body temperature increased—Methotrexate—muscle cancer	0.00078	0.00136	CcSEcCtD
Levonorgestrel—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000779	0.00135	CcSEcCtD
Levonorgestrel—Insomnia—Doxorubicin—muscle cancer	0.000773	0.00134	CcSEcCtD
Levonorgestrel—Dyspnoea—Doxorubicin—muscle cancer	0.000762	0.00132	CcSEcCtD
Levonorgestrel—Somnolence—Doxorubicin—muscle cancer	0.00076	0.00132	CcSEcCtD
Levonorgestrel—Dyspepsia—Doxorubicin—muscle cancer	0.000752	0.00131	CcSEcCtD
Levonorgestrel—Decreased appetite—Doxorubicin—muscle cancer	0.000743	0.00129	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000738	0.00128	CcSEcCtD
Levonorgestrel—Fatigue—Doxorubicin—muscle cancer	0.000737	0.00128	CcSEcCtD
Levonorgestrel—Pain—Doxorubicin—muscle cancer	0.000731	0.00127	CcSEcCtD
Levonorgestrel—Constipation—Doxorubicin—muscle cancer	0.000731	0.00127	CcSEcCtD
Levonorgestrel—Hypersensitivity—Methotrexate—muscle cancer	0.000727	0.00126	CcSEcCtD
Levonorgestrel—Asthenia—Methotrexate—muscle cancer	0.000708	0.00123	CcSEcCtD
Levonorgestrel—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000699	0.00121	CcSEcCtD
Levonorgestrel—Pruritus—Methotrexate—muscle cancer	0.000698	0.00121	CcSEcCtD
Levonorgestrel—Urticaria—Doxorubicin—muscle cancer	0.000679	0.00118	CcSEcCtD
Levonorgestrel—Abdominal pain—Doxorubicin—muscle cancer	0.000675	0.00117	CcSEcCtD
Levonorgestrel—Body temperature increased—Doxorubicin—muscle cancer	0.000675	0.00117	CcSEcCtD
Levonorgestrel—Diarrhoea—Methotrexate—muscle cancer	0.000675	0.00117	CcSEcCtD
Levonorgestrel—Dizziness—Methotrexate—muscle cancer	0.000653	0.00113	CcSEcCtD
Levonorgestrel—Hypersensitivity—Doxorubicin—muscle cancer	0.00063	0.00109	CcSEcCtD
Levonorgestrel—Vomiting—Methotrexate—muscle cancer	0.000627	0.00109	CcSEcCtD
Levonorgestrel—Rash—Methotrexate—muscle cancer	0.000622	0.00108	CcSEcCtD
Levonorgestrel—Dermatitis—Methotrexate—muscle cancer	0.000622	0.00108	CcSEcCtD
Levonorgestrel—Headache—Methotrexate—muscle cancer	0.000618	0.00107	CcSEcCtD
Levonorgestrel—Asthenia—Doxorubicin—muscle cancer	0.000613	0.00107	CcSEcCtD
Levonorgestrel—Pruritus—Doxorubicin—muscle cancer	0.000605	0.00105	CcSEcCtD
Levonorgestrel—Nausea—Methotrexate—muscle cancer	0.000586	0.00102	CcSEcCtD
Levonorgestrel—Diarrhoea—Doxorubicin—muscle cancer	0.000585	0.00102	CcSEcCtD
Levonorgestrel—Dizziness—Doxorubicin—muscle cancer	0.000565	0.000982	CcSEcCtD
Levonorgestrel—Vomiting—Doxorubicin—muscle cancer	0.000543	0.000944	CcSEcCtD
Levonorgestrel—Rash—Doxorubicin—muscle cancer	0.000539	0.000936	CcSEcCtD
Levonorgestrel—Dermatitis—Doxorubicin—muscle cancer	0.000538	0.000935	CcSEcCtD
Levonorgestrel—Headache—Doxorubicin—muscle cancer	0.000535	0.00093	CcSEcCtD
Levonorgestrel—Nausea—Doxorubicin—muscle cancer	0.000508	0.000882	CcSEcCtD
